Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study.
Mao-Draayer Y, Cohen JA, Bar-Or A, Han MH, Singer B, Williams IM, Meng X, Elam C, Weiss JL, Cox GM, Ziehn M, Cree BA; FLUENT study investigators.
Mao-Draayer Y, et al. Among authors: elam c.
Mult Scler J Exp Transl Clin. 2022 Aug 1;8(3):20552173221115023. doi: 10.1177/20552173221115023. eCollection 2022 Jul-Sep.
Mult Scler J Exp Transl Clin. 2022.
PMID: 35936922
Free PMC article.